Show Notes

In two companies, Nick Brignola, has shown the power of FP&A steering big ticket medical acquisitions. Firstly,  almost a decade ago, Nick led FP&A at manufacturing medical company, Schering-Plough snapped up by Merck in a $41.1 billion deal. Then in June 2022, at Cloudmed, Nick’s FP&A team oversaw the Atlanta-based healthcare revenue recovery provider being acquired by Revenue cycle management company R1 RCM ( $4.1 billion). In this straight-talking episode Nick reveals the secret inside story of FP&A's behind the scenes role in closing M&A deals. He also discusses:

• Getting to 1% Forecast Accuracy in Pharma and the lessons others can learn.

• The vital metrics anyone in pharma manufacturing need to know.

• What are the main differences betweeen Corporate FP&A or Business Unit (or operational) FP&A?

• FP&A Vs Sales The secret for FP&A teams to truly challenge your sales team (productively)

• His secrets to building the most effective and dynamic FP&A team which bring results

Follow everyone from this episode:

• Follow Nick Brignola on LinkedIn

• Follow Paul Barnhurst on LinkedIn

• Follow Datarails on LinkedIn

• FP&A Today is brought to you by Datarails.

Datarails is the financial planning and analysis platform that automates data consolidation, reporting and planning, while enabling finance teams to continue using their own Excel spreadsheets and financial models.

• Get in touch at www.datarails.com

• Read the Blog and Full Program Transcript

• Watch the Full Episode on YouTube

To suggest a great guest for the show, or if you would like to be the FP&A Leader being interviewed contact jonathan.m@datarails.com

YouTube Video